Name 3 CAR-T products that are currently approved by the FDA ?
Tisagenlecleucel for patients 25 years and younger with refractory ALL AND for adults with relapses/refractory diffuse large b-cell lymphoma; Axicabtagene ciloleucel for adult patients with diffuse large b-cell lymphoma; Brexucabtagene autoleucel for adults with mantle cell lymphoma.
Lipe DM and Shafer S. CAR-T and checkpoint inhibitors: toxicities and antidotes in the emergency department. Clin Tox 2021; Ahead of print: 1-17. https://doi.org/10.1080/15563650.2021.1880008
Posted in Question Of The Day